|
1
|
Patocka J: Biologically active pentacyclic
triterpenes and their current medicine signification. J Appl
Biomed. 1:7–12. 2003.
|
|
2
|
Phillips DR, Rasbery JM, Bartel B and
Matsuda SP: Biosynthetic diversity in plant triterpene cyclization.
Curr Opin Plant Biol. 9:305–314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jager S, Trojan H, Kopp T, Laszczyk MN and
Scheffler A: Pentacyclic triterpene distribution in various plants
- rich sources for a new group of multi-potent plant extracts.
Molecules. 14:2016–2031. 2009.PubMed/NCBI
|
|
4
|
Baek JH, Lee YS, Kang CM, Kim JA, Kwon KS,
Son HC and Kim KW: Intracellular Ca2+ release mediates
ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J
Cancer. 73:725–728. 1997.
|
|
5
|
Yamaguchi Y, Yamada K, Yoshikawa N,
Nakamura K, Haginaka J and Kunitomo M: Corosolic acid prevents
oxidative stress, inflammation and hypertension in SHR/NDmcr-cp
rats, a model of metabolic syndrome. Life Sci. 79:2474–2479. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duke JA and Ayensu ES: Medicinal Plants of
China. 2. Reference Publications Inc; Algonac, MI, USA: pp.
3811985
|
|
7
|
Hedrick UP: Sturtevant’s Edible Plants of
the World. Dover Publications; Mineola, NY, USA: pp. 6861972
|
|
8
|
Lee HH, Lin CT and Yang LL:
Neuroprotection and free radical scavenging effects of Osmanthus
fragrans. J Biomed Sci. 14:819–827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fernandes J, Weinlich R, Castilho RO,
Kaplan MAC, Amarante-Mendes GP and Gattass CR: Pomolic acid
triggers mitochondria dependent apoptotic cell death in leukemia
cell line. Cancer Lett. 219:49–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fernandes J, Weinlich R, Castilho RO,
Amarante-Mendes P and Gattass CR: Pomolic acid may overcome
multidrug resistance mediated by overexpression of anti-apoptotic
Bcl-2 proteins. Cancer Lett. 245:315–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vasconcelos FC, Gattass RR, Rumjanek VM
and Maia RC: Pomolic acid-induced apoptosis in cells from patients
with chronic myeloid leukemia exhibiting different drug resistance
profile. Invest New Drugs. 25:525–533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshida M, Fuchigami M, Nagao TT, et al:
Antiproliferative constituents from umbelliferase plants VII.
Active triterpenes and rosmarinic acid from Centella
asiatica. Biol Pharm Bull. 28:173–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng TS, Schlosser SF, Dao T, Hingorani
R, Crispe IN, Boyer JL and Flavell RA: Caspase-3 controls both
cytoplasmic and nuclear events associated with Fas-mediated
apoptosis in vivo. Proc Natl Acad Sci USA. 95:13618–13623.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee B, Lee DY, Yoo KH, Baek NI, Park JH
and Chung IS: Calenduloside E 6’-methyl ester induces apoptosis in
CT-26 mouse colon carcinoma cells and inhibits tumor growth in a
CT-26 xenograft animal model. Oncol Lett. 4:22–28. 2012.
|
|
16
|
Sung B, Park B, Yadav VR and Aggarwal BB:
Celastrol, a triterpene, enhances TRAIL-induced apoptosis through
the down-regulation of cell survival proteins and up-regulation of
death receptors. J Biol Chem. 285:11498–11507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prasad S, Yadav VR, Kannappan R and
Aggarwal BB: Ursolic acid, a pentacyclin triterpene, potentiates
TRAIL-induced apoptosis through p53-independnet up-regulation of
death receptors. J Biol Chem. 286:5546–5557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoo KH, Park JH, Cui EJ, et al:
3-O-Acetyloleanolic acid induces apoptosis in human colon carcinoma
HCT-116 cells. Phytother Res. View
Article : Google Scholar : 2012.PubMed/NCBI
|
|
19
|
Pitti RM, Marsters SA, Ruppert S, Donahue
CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2
ligand, a new member of the tumor necrosis factor cytokine family.
J Biol Chem. 271:12687–12690. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L and Fang B: Mechanisms of
resistance to TRAIL-induced apoptosis in cancer. Cancer Gene
Therapy. 12:228–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ashkenazi A and Dixit VM: Death receptors:
Signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wajant H, Gerspach J and Pfizenmaier K:
Tumor therapeutics by design: targeting and activation of death
receptors. Cytokine Growth Factor Rev. 16:55–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
